scispace - formally typeset
A

Ali Ouaissi

Researcher at University of Montpellier

Publications -  81
Citations -  2895

Ali Ouaissi is an academic researcher from University of Montpellier. The author has contributed to research in topics: Trypanosoma cruzi & Leishmania infantum. The author has an hindex of 32, co-authored 81 publications receiving 2757 citations. Previous affiliations of Ali Ouaissi include French Institute of Health and Medical Research & Instituto de Biologia Molecular e Celular.

Papers
More filters
Journal ArticleDOI

Axenically Grown Amastigotes of Leishmania infantum Used as an In Vitro Model To Investigate the Pentavalent Antimony Mode of Action

TL;DR: Results were consistent with the hypothesis of an intramacrophagic metabolic conversion of Sb(V) into trivalent compounds, which in turn became readily toxic to the Leishmania amastigote stage.
Journal ArticleDOI

Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes.

TL;DR: The results demonstrate that the antileishmanial toxicity of Sb(III) antimonials is associated with parasite oligonucleosomal DNA fragmentation, indicative of the occurrence of late events in the overall process of apoptosis.
Journal ArticleDOI

The Trypanosoma cruzi Tc52-released protein induces human dendritic cell maturation, signals via Toll-like receptor 2, and confers protection against lethal infection.

TL;DR: It is reported that immunization with Tc52 protects mice in vivo against lethal infection with T. cruzi, and the immune protection data suggest that Tc 52 is among candidate molecules that may be used to design an optimal multicomponent vaccine to control T. cruiser infection.
Journal ArticleDOI

Advances and perspectives in Leishmania cell based drug-screening procedures.

TL;DR: This review will focus on available methodologies for direct drug screening purposes against the mammalian stage of the parasite, with emphasis on the future developments that could improve sensitivity, reliability, versatility and the throughput of the intracellular model screening.